Objective-To investigate the significance of functional polymorphisms of inflammatory response genes by analysis of a large population of patients, both with and without severe sepsis, and representative of the diverse populations (geographic diversity, physician diversity, clinical treatment diversity) that would be encountered in critical care clinical practice.
Gender of the patient with sepsis is also implicated as a prognostic factor for severe sepsis in both clinical [1, 19] and basic science studies [20] . Beneficial effects of estrogen through cytokine modulations of female patients with septic insults have been examined by experimental studies [20, 21] . Meanwhile, human [22, 23] and animal [24] studies have also demonstrated that the elderly experience more severe inflammatory responses and are more vulnerable to severe sepsis than the young due to dysregulation of cytokine storm. However, the biological basis of these differences is more complex than simply the presence or absence of sex hormones and may be modulated by genetic background and inflammatory gene expression [25, 26] . According to experts [15, 27, 28] , issues in population genetics studies that complicate the correlation with clinical events in addition to inadequate statistical power include the heterogeneity of population subgroups, difficulty in acquiring matched control groups, genetic factors obscured by overwhelming disease pathophysiology, genetic variants that have undefined pathogenic consequences on gene function, and the low allele frequency of some polymorphic variants.
Herein, we report on functional polymorphisms of six inflammatory response genes following analysis of a large and diverse population of patients both with and without severe sepsis from 12 medical centers in the USA. In this project, we used the Project IMPACT™ (PI) critical care clinical database information management system developed by the Society of Critical Care Medicine (SCCM) to facilitate the prospective collection of clinical samples for genetic analysis using a case-control design. Control patients were selected from those admitted to the same ICUs and having the same gender, age, race and outcome but absent severe sepsis. Simultaneously, we established a high-throughput, cost-effective genotyping of samples by introducing the template-directed dye-terminator incorporation assay with fluorescence polarization (TDI-FP) detection [29] . On the basis of the results of population association, we performed further assessment on the joint association between heritable and acquired factors with conventional tools and with recursive partitioning analysis.
[Materials and Methods] Design and data source of 'Genetic Predisposition to Severe Sepsis' Project
Critically ill patients from 12 intensive care units across the United States were studied as part of the Genetic Predisposition to Severe Sepsis (GenPSS) project. The study was designed to assess the significance of functional polymorphisms of inflammatory response genes by analysis of a large, diverse population of patients both with and without severe sepsis from geographically distinct medical centers with different clinicians and operating procedures. All participating clinical centers utilized the Project IMPACT (PI) database information management system developed by the Society for Critical Care Medicine (SCCM) and managed by Tri-Analytics, Inc. (http://www.trianalytics.com/, accessed 2Jan2009) and Cerner Corporation (Kansas City, MO). This database provided the separation of the patients' identity and personal health information (PHI) from the central laboratory where genotyping was performed. PHI was scrubbed or masked from patient records by Tri-Analytics prior to delivery of clinical outcome data to the investigators. As the intended consequence of this study design (which also relied upon the use of waste blood, vide infra), the study was approved for conduct with waiver of written informed consent. The project design also meets the confidentiality and specimen access controls required of a typical NIGMS Human Genetic Cell Repository (http://ccr.coriell.org/Sections/ Collections/NIGMS/?SsId=8 , accessed 2Jan2009).
Patient Selection and Definitions
The PI database was queried across the study period of July 2001 to December 2005 to identify specimens of blood submitted from 854 patients with unambiguous severe sepsis (SS) and an equal number of similar mortality, age (matched within a 10-yr margin), gender, and race matched controls (MC) without evidence of any infection during their ICU stay. The diagnosis of severe sepsis was made when a patient met the criteria proposed by the American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference [30] . We used a previously validated approach to the identification of severe sepsis involving the co-occurrence of International Classification of Diseases, Ninth Revision (ICD-9) codes for a bacterial or fungal infectious process and acute organ dysfunction using the following Boolean logic criteria ( Fig. 1 ) [31] :
Logic 1-Severe Sepsis at Admission/Physiology Within First 24 hrs: Criteria 1 AND 2 fulfilled-

1.
Severe Sepsis at Admission Selection of Matched Controls-Controls were matched as follows: Participating centers submitted similar blood samples from critically ill patients who were not known to be septic, recognizing that some would become septic during the ICU stay. Most who were not septic on admission did not become septic during the ICU stay. All patients who did not meet severe sepsis criteria were placed into the matching pool, and those who had any evidence of infection were then excluded. This left a pool of potential non-sepsis match candidates who had no evidence of infection during their hospitalization as recorded in the PI database. Each septic patient was tentatively matched with all patients in the pool of the same gender, reported race/ethnicity and hospital discharge status (alive versus dead). Age matches were allowed +/− 10 years. Then, each severely septic patient was matched with one patient from its set of potential non-sepsis matches. If there was only one possible match for the septic patient, the match was assigned and then the match was removed from the pool. If more than a single matching patient was identified, then the match was made by selecting one of the potential matches at random, and then removing that match from the pool. The algorithm ran recursively until a match was made for each septic patient. In the event that a match corresponded to a sample that failed to yield DNA that could be analyzed, the algorithm was re-run against remaining matches in the control pool.
Occasionally, patients would have more than one ICU admission during a single hospitalization. If the patient was severely septic on any ICU admission, the patient was judged severely septic for that hospitalization and therefore could not also be used as a matched control. To promote confidentiality, genotyping lab personnel did not have information about the medical center, physician or patient from which the blood spot card originated. The PI personnel did not have access to genotyping determinations or the local GenPSS database at any time. The information management personnel queried the clinical PI database to identify specimens submitted from patients enrolled in GenPSS at participating ICUs without revealing any protected health information (PHI) to the genotyping lab personnel. Bar code identifiers were selected for PI records that corresponded to patients with severe sepsis and the matched control patients who did not have evidence of any infection at any time during their hospital course.
Specimen Collection and Patient Confidentiality
DNA Isolation
Using a 3 mm paper hole punch (McGill Inc., Marengo, IL), 2 FTA paper discs from the dried blood stain were punched out and placed in each tube of 8-strip thin wall tubes (MIDSCI, St. Louis, MO). DNA Elution Solution (PureGene, Qiagen (formerly Gentra Systems, Inc.) , MD) was added (200 μL per tube) and incubated overnight at 4°C. After incubation, the DNA elution solution was discarded. DNA purification solution (Gentra, Minneapolis, MN) 150 μL was added, incubated for 15 minutes at room temperature, mixed and discarded. This step was repeated 2 to 4 times until a colorless wash was obtained. DNA elution solution was added to the washed paper punches in each tube and incubated for 15 minutes. After removing as much solution as possible, DNA elution buffer was finally added to each tube. The sealed tubes were incubated for 15 minutes at 99°C within a MJ Research 225 Tetrad Thermal Cycler (GMI, Ramsey, MN) to facilitate release of the bound DNA from the paper discs. The eluted DNA was transferred to a fresh tube and stored at 4°C.
Polymerase Chain Reaction
We developed assays for 6 functional SNPs present in inflammation-related genes implicated as mediators of the sepsis cascade. These include SNPs present before the first codon of TNF at −308, IL1B at −511, IL6 at −174, IL10 at −819, and CD14 at −159 (TNF(−308)) [6] [7] [8] , IL1B(−511) [33] [34] [35] , IL6 (−174) [36, 37] , IL10 (−819) [38, 39] , and CD14 (−159) [40, 41] ), and in the first intron of lymphotoxin-α (formerly known as TNF-β) at +252 (LTA(+252) [42, 43] . These 6 polymorphisms were selected from 22 candidate markers related to systemic inflammation based on our preliminary analysis of a separate pilot patient cohort. We focused on genes whose products had a known functional role in the inflammatory response [35, 39, [43] [44] [45] [46] [47] .
Two microliters (μL) of genomic DNA (5 to 10 nanograms) was amplified in a mixture containing 2.5 μL of AmpliTaq Gold® PCR Master Mix (Applied Biosystems, Foster City, CA), 0.05 μL 50 mmol/L mixture of forward and reverse primer (Integrated DNA Technologies, Inc., Coralville, IA), 1.45 μL double-distilled water according to the conditions listed in Table 1a . To optimize the TDI-FP technique, PCR primers and conditions were designed to generate a homogeneous PCR product of 400 bp or smaller using Primer Premier ver. 5.0 software (Biosoft International, Palo Alto, CA). All reactions were performed in 0.2 mL black-skirted 96-well reaction plates (ABgene, Surrey, UK) with the MJ Research 225 Tetrad Thermal Cycler (BioRad, Hercules, CA).
Amplicon Purification
To eliminate unincorporated single-stranded PCR primers and dNTPs which may reduce the specificity of the TDI-FP reaction, E. coli exonuclease 1 (New England Biolabs, Inc., Ipswich, MA) (0.1 μL), shrimp alkaline phosphatase (SAP; Roche Molecular Biochemicals, Indianapolis, IN) (1.0 μL), 10× SAP reaction buffer (0.2 μL), pyrophosphatase (Perkin Elmer Life Sciences, Inc, Boston, MA) (0.15 μL), and double-distilled water (0.55 μL) were added to the total volume of PCR product (6.0 μL) and incubated at 37°C for 60 minutes, followed by 85°C for 25 minutes for enzyme inactivation. Pyrophosphatase was omitted from the purification of the PCR products of TNF(−308) and LTA(+252).
Template-directed Dye-terminator Incorporation Reaction (TDI)
For all assays, we used the single-base extension SNP genotyping kit AcycloPrime™ FP SNP Detection from Perkin Elmer Life Sciences, Inc, Boston, MA. The purified PCR product was combined with 0.05 μL AcycloPol™ thermostabile polymerase, 2.0 μL of 10 × AcycloPrime™ Reaction Buffer, 1.0 μL of specific AcycloTerminator™ mix consisting of R110/TAMRA-labeled dideoxynucleotide pairs for each SNP variant, 1.0 μL of the sitespecific TDI oligonucleotide probe, 10 μmol/L (Table 1a ; Integrated DNA Technologies, Inc., Coralville, IA), and 8.95 μL double-distilled water. The final reaction volume was 21 μL. The reactions were incubated according to the conditions specified in Table 1b . The TDI oligonucleotide probes were 20 to 30 nucleotides designed to complement the sequence immediately adjacent to the SNP position. Annealing temperatures were selected to be approximately 10°C below the melting temperature of the oligonucleotide probe DNA sequence.
Fluorescence Polarization Determination
Fluorescence polarization (FP) values were directly measured using an Analyst AD fluorescence reader (Molecular Devices, Sunnyvale, CA) with excitation and emission wavelengths of 580 nm and 605 nm for R110, and 552 nm and 575 nm for TAMRA, respectively. For LTA(+252), IL6(−174), and CD14(−159), 0.1 μL of single-stranded DNA binding protein (Epicentre Biotechnologies, Madison, WI), 0.2 μL of 10× SAP reaction buffer, and 1.7 μL water were added to each TDI reaction product and incubated at 37°C for 60 minutes before FP determination. For the remainder of the SNPs analyzed, FP was determined immediately following the TDI reaction.
Between reaction steps (i.e., PCR, amplicon purification, TDI reaction, and incubation with single-stranded DNA binding protein) reaction plates were thermally sealed with adhesive sealing sheets (Brinkmann Instruments, Inc., Westbury, NY) and pulse centrifuged to minimize evaporative loss and cross contamination.
Allele Assignment
Allele assignment was objective and used SNPscorer software (Perkin Elmer Life Science, Inc at www.snpscoring.com, Samples that remained ambiguous following the first analysis were re-analyzed using identical methodology or direct DNA sequencing. Samples were considered of indeterminate genotype if allele assignment could not be made after two repetitions of TDI-FP methodology and sequencing. To confirm the accuracy of our approach, sequence-verified controls for each genotype were incubated in every TDI-FP assay performed. As a validity check, five percent of the TDI-FP calls were verified by conventional DNA sequencing.
Gene and Clinical Data Analysis
In addition to standard strategies, we employed recursive partitioning (RP) as a tool to identify relevant genetic and non-genetic predictors. We used HelixTree™ software (Golden Helix Inc, Bozeman, MT) for RP analysis. RP can be most easily viewed as conditional feature finding. Once a split is made based upon one gene/clinical feature, then the subsequent analysis is conditional on the presence or absence of that gene or clinical feature. Examination of a particular clinical outcome suggests that the effect of any feature will be, at least in part, dependent on the presence/absence of other features.
Statistical Analysis
Hardy-Weinberg equilibrium for the population distribution of the variant alleles was determined according to the approach described by Guo and Thompson [48] . Allelic chisquares were also examined for each SNP. Strict Bonferroni correction is considered to be overly conservative, therefore a Bayesian formula was applied to obtain 0.95 posterior probability of a correct influence of association to a particular gene. In preliminary analysis, we considered differences significant at P < .05. In order to improve the likelihood that observed differences were not the result of a Type 1 error, we set final significance at P < . 01.
Results
Characteristics of Severely Septic and Matched Control Patients
The characteristics of 854 severely septic (SS) and matched non-septic control (MC) patients are listed in Table 2 . In both groups, 53.6 % were male, 87.2 % and 6.4 % were Caucasian and African American patients, respectively, and overall survival was 64.9 % ( Fig. 3 ). In spite of their similar mortality, the MC patients had no evidence of infection at any time during their hospitalization. Average ages (SD) of SS and MC groups were 63.0 (16.05) and 65.0 (15.58) years old, respectively ( Fig. 3 ) and the distribution of the age in each cohort was similar (F = 1.06, P = 0.389). The non-septic patients were selected as directed matches in terms of gender, age race and survival from the same Project IMPACT ™ database ( Fig  1) . By design, the cohort of control ICU patients are well-matched on these selected variables to the patients with severe sepsis.
Genotyped Specimens are Representative of the Total Severe Sepsis Population
Distributions of gender, age, race and outcome between the genotyped SS and the total SS were compared (Fig. 3 ). The mean age (SD) was 64.4 (16.12) years old and 52.3 % were men in total SS of PI database (n = 21265; Fig. 3 ). In this total population, 79.0 % and 15.0 % were Caucasian and African-American, respectively. Caucasians were slightly overrepresented in the genotyped population, most likely the result of the patient populations in the institutions that chose to participate in the study. The distribution of age between the total SS and the genotyped SS was similar (F = 1.01, P = .885). The survival rate in total SS population (60 %) was slightly lower than the genotyped SS population (64%). Overall, as illustrated in Fig. 3 , genotyped specimens are fairly representative of the total severe sepsis population.
Genotypic Distributions of the Six Inflammation Gene Polymorphisms and Frequency of Severe Sepsis in the Genotype Categories
Genotype call rate of the six SNPs was 91.4 -99.0 % although genotypic distributions in TNF (−308), LTA(+252) and IL1B(−511) diverged from Hardy-Weinberg equilibrium (HWE) in the studied subjects (P = .0013, < .0001 and .0065, respectively; Table 3 ). As expected given their collocation on chromosome 6, TNF(−308) and LTA(+252) were in linkage disequilibrium (LD correlation R = .4523, D' = .7819, P < .0001). LTA(+252) was the marker among the 6 SNPs which was the most over-represented in the septic patient group with codominant (additive) model analysis and therefore significantly associated with the sepsis susceptibility in terms of dose effect of alleles (P = .005; Fig 4) . IL6(−174), CD14(−159) and IL1B(−511) also maintained the allele dose effect although their splits trend did not reach statistical significance. As for TNF(−308), the genotype distribution of variant homozygotes (AA) was too low (3.59 %; Table 3 ) to evaluate the frequency of severe sepsis occurrence. It appears that, in this large and geographically diverse population of the critically ill patients, LTA(+252) genotype influences the risk of developing severe sepsis. and age and gender on susceptibility to severe sepsis. As shown in Fig. 5 , in male population (P = .0026), LTA(+252) had significantly larger influence on severe sepsis risk than female population (P = .5870). In both gender groups, older (> 60 yrs) patients were more susceptible to severe sepsis, which was consistent with the results in Table 4 . Although all populations exhibited the allele dose effect, there was statistical significance only in the older male population (P = .0051). Recursive partitioning indicated that the effect of LTA(+252) on severe sepsis risk was concentrated primarily in the older male members of the patient population.
Lymphotoxin-α intron Polymorphism and Severe Sepsis after Gender, Age and Racial Stratification
To verify the effects suggested by recursive partitioning, we formally tested the association between the sepsis case status and the marker a LTA(+252) adjusting for potential nongenetic covariates using a full versus reduced logistic regression approach based on an additive genotypic model. 
Discussion
This study shows that in a large and heterogeneous population of critically ill patients who received medical care in diverse settings, a variant allele of the LTA gene is associated with increased risk of severe sepsis. This finding is important because prior studies have generally focused on care of a single ethnic group or care at a single medical center, and often report findings in relatively small study populations [49] . Moreover, this adverse effect of the variant allele of LTA(+252) on susceptibility to severe sepsis in this study is influenced by non-modifiable characteristics of gender and age (Fig. 5 ). The adverse effect of the LTA(+252)G on male patients is also reminiscent of the previous report by Schröder [19] . However, the surprising finding in the present study is that the influence of LTA(+252)G presence on the predisposition to severe sepsis is modified not only by gender (male) but also by age (elderly). Furthermore, the present study has more statistical power than the previous study plus the severe sepsis risk was evaluated with a completely matched control population among patients registered in the Project IMPACT™ (PI) database. This result suggests that inflammatory cytokine production is somewhat regulated by LTA(+252) in sepsis pathophysiology and the genetic risk association may be more pronounced among elderly male patients. Although the genotype distributions of LTA(+252) did not differ between young and elderly nor between male and female (Table 4) , the largest genetic association appeared in older male patients. Interpretive caution is advised since a significant result in one subgroup and a lack of statistical significance in another does not necessarily signify a different effect according to subgroup. The interaction statistics between subgroups were not significant. 
Author Manuscript
Author Manuscript
Stewart, et al. and Marik, et al. have consistently shown that TNF production by the elderly was higher in severe biliary infections [23] and more generally in septic shock [22] . As for sexual dimorphism, Moxley, et al. demonstrated that LPS-stimulated TNF levels in peripheral blood of healthy female patients were lower than in blood of male patients [21] . Although the study design did not provide for measurements of cytokines, we speculate that their concentration might be significantly stratified by LTA(+252) especially in older male ICU patients. Furthermore, a recent report suggested that gene expression variance in critically ill patients due to age, gender, and ethnic background is greater than that due to infecting organism [50] . Our study failed to recruit a sufficient number of African-Americans with severe sepsis to reach reliable statistical inferences concerning any influence that race/ethnicity might have on sepsis predisposition phenotype among carriers of the various LTA(+252) alleles. Many of the contributing centers were community-based. Of note, there was no statistical difference in the frequency of African-Americans in those centers who did and who did not have genetic specimens contributed.
Contrary to prior reports, many of the genetic polymorphisms besides LTA(+252) that had been already reported as predictors of severe sepsis did not demonstrate a statistically significant effect on sepsis risk. Thus variant allele carriers of CD14(−159) appeared somewhat less susceptible to severe sepsis in our result ( Fig. 4) , which is inconsistent with a published report [41] even if the influence of CD14(−159) in our result was not significant. This apparent discrepancy might be partially due to the larger size of our study or to differences in control selection. In our study, the US ICU patients from 12 the different centers who had no evidence of any infections were selected as control. In contrast, earlier studies that reported rare allele of CD14(−159) had adverse effect on sepsis risk chose healthy volunteers in a single center as their controls [40, 41, 51] .
The early enthusiasm fueled by smaller studies that suggested the existence of a number of gene variants that might predispose to sepsis and/or an adverse outcome has been dampened by the realization that many of those studies were underpowered, their findings were likely falsely positive and their conclusions were unwarranted [49] . This concern applies to LTA (+252), which has previously been reported in smaller studies to both confer ( 5 studies) and not to infer (8 studies) an increased risk of sepsis [49] . One approach to minimizing the risk of falsely positive attributions is the calculation of a false positive report probability (FPRP) [52] . Even setting a conservative FPRP value of 0.2 still suggests that the observed influence of LTA(+252) on severe sepsis predisposition in our study to be noteworthy.
A sufficiently powered, carefully described whole genome study in sepsis genomics appears important to understanding both sepsis biology as well as the interplay among genetic and non-genetic influences upon susceptibility and outcome. The importance of comprehensive clinical databases that collect not only demographic data and pre-existing conditions but also describe the septic event in detail-including all causative organisms, putative sources, treatments and apparent success or failure-cannot be overstated. Such process variables allow for rigorous disease-based grouping (e.g., analysis of patients with pneumococcal pneumonia) as opposed to the current stopgap strategy of syndrome-based grouping (e.g. severe vs. mild sepsis).
Comprehensive clinical data contained in PI and similar databases enable not only close matching of cases and controls, but also some insight into selection bias that might affect the cases themselves. The specimens from patients with severe sepsis in the GenPSS archive appeared to be representative of the total severe sepsis population from the PI database ( Fig.  3 ). Yet there was a difference in survival rate between 'genotyped SS v total SS patients' (64.87 v 60.72 %, P = .0102; Fig. 3 ) that might reflect differences in the approach of participating centers to the care of severely septic patients. Although the genotype failure rate approached 9% for some alleles, this appeared to be unrelated to the contributing center or to patient status (severe sepsis versus matched controls). Provided that the failure was unrelated to a specific allele, modeling suggests that the no additional SNPs would have become significant if genotype failures had not occurred
Alternatively, there may be more complex genetic effects. In our ICU patients' cohort, there are deviations from Hardy-Weinberg equilibrium (HWE) on LTA(+252). The Fisher's Exact HWE test p-value is 1.21 × 10 −5 and the HWE correlation R value is 0.10696. When cases and controls are considered separately, the Fisher's exact HWE p-value is 0.00226 for cases and 0.00346 for controls for the LTA(+252) marker. Thus there is evidence to suggest that the association between the septic shock response and this marker is not driven by departures from HWE. It is important to note that the samples were not randomly drawn from a population, but instead were taken from patients admitted to the ICU. The LTA(+252) marker has been shown in previous studies to be associated with both sepsis and respiratory failure [53] . The likelihood of cases and controls suffering from either sepsis, respiratory failure or both is greater than would normally be found in the general "healthy" population, plausibly accounting for the departures from HWE. Plausible is different from certain, thus one can only conclude that for some genotypes evaluated, the alleles were not assorted randomly in the population under study.
We believe that the intersection of clinical care and disease association genetics demands study of large (>100,000) populations whose clinical data are rigorously recorded and whose genomes are studied in their entirely. The costs of such an effort, previously prohibitive, are now mitigated by the US federal requirements for portable electronic records and advances in the efficiency of screening techniques. The risks of such an effort, primarily related to the potential for discrimination should genetic data leak to payors and insurers, have been mitigated by passage of the Genetic Insurability Nondiscrimination Act (GINA) signed into US law on April 24, 2008.
Our mid-scale population association study supports the hypothesis that genetic predisposition to severe sepsis exists and is further modulated by both genetic (gender) and non-genetic (age) factors. Variation in the LTA(+252) gene appears to explain, in part, the susceptibility to sepsis and the effect may be greater in older Caucasian men.
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Appendix: Report of power calculations
Our study suggested that three SNPs maintained an allele dose effect although the splits trend did not reach statistical significance. In order to help the reader interpret the data and this statement, we performed and provide power calculations that vary with posited genetic effect and also with minor allele frequency assuming 854 case-control pairs, a severe sepsis rate of 5% in the ICU population, and a two-tailed α = 0.01. The calculations were performed with Quanto, a freely downloadable application offered by the University of Southern California and available at http://hydra.usc.edu/gxe/.
Three models are presented. The first model, the dominant model, assumes that either one or two copies of the minor allele is sufficient to predispose to severe sepsis. The second model, the log-additive or coDominant model, assumes that two copies of the minor allele have double the probability of predisposing to severe sepsis. The third model, the recessive model, requires two copies of the minor allele to predispose to severe sepsis. Since there is no way of knowing how the minor allele might have its effect in advance, all three models are considered.
For each of the models, a range of minor allele frequencies ranging from 0.18 to 0.38 is illustrated. A minor allele frequency of 0.18 corresponds approximately to the lowest frequency observed among the six minor alleles, that of TNF(−308). The highest frequency shown corresponds to the frequency of the minor allele of LTA(+252).
The power calculation also depends on the degree of genetic predisposition. This is shown in the table as the RG, which can be thought of the increased odds of becoming septic if the model conditions are fulfilled. These are shown from 1.25 to 2.5 for each model. Each combination of model, minor allele frequency, and odds ratio produces a unique power value. A value of 0.8 corresponds to 80% , meaning that the study has an 80% probability of detecting the effect if the effect exists. Again, we set the p-value at a conservative 0.01.
These data are calculated for single genes. They do not account either for gene-gene interactions or for multiple comparisons. Moreover they are power calculations only and have no influence on the analysis of the data.
The table shows that if two copies of the minor allele are required to predispose to severe sepsis(recessive model), then either the minor allele must be relatively frequent or else the predisposition must be substantial (e.g. doubling the risk). Workflow of genotyping in the GenPSS project Figure 2 illustrates our strategy for high-throughput, cost-effective genotyping of samples in this GenPSS project. ICUs sent waste blood samples collected on a filter paper card (a). On this card, randomly-generated Bar-coded numbers (in the red circle*) were prepared to protect the confidentiality of individual patient. DNA for genotyping was isolated from these blood stains. First, we amplified the target region of DNA by PCR with primers specific for the sequences of each of our 6 selected markers. After a clean-up step of the PCR products to remove unused primers and nucleotides, we added a unique oligonucleotide probe molecule for the sequence-specific, single nucleotide extension step using dideoxyterminator nucleotides (ddNTPs). This is the TDI-FP as the high-throughput method for SNP analysis. PCR, Exo SAP, TDI reaction procedures were performed using a tetrad thermal cycler (b). FP values were directly measured using an Analyst AD fluorescence reader (c). In the result view which appears in the excel sheet (d), small dots indicate FP values obtained for individual patients' samples and identification of specific genotype clusters from the TDI reaction. GenPSS, Genetic Predisposition to Severe Sepsis; PCR, polymerase chain reaction; Exo SAP, E. coli exonuclease 1 and shrimp alkaline phosphatase; TDI, template-directed dyeterminator incorporation; ddNTP, dideoxynucleotide triphosphate; FP, fluorescence polarization; DB, database; SNP, single nucleotide polymorphism. . Table 4 Chi-square test on allelic frequencies and genotype distributions with respect to the predisposition to severe sepsis in the lymphotoxin alpha first intron polymorphism .9908
Power
Minor Allele Frequency
.0039
LTA(+252), single nucleotide polymorphism at position 252 site of lymphotoxin-α.
